Based in Marlton, New Jersey, Ellington Healthcare Partners I seeks to invest up to $25 million in each company. Managed by Ellington Healthcare Asset Management LLC, the fund targets innovative bio-pharma developments and regenerative medicine. With a focus on oncology, bone marrow-derived cells, stem cells, and oncology firms, Ellington Healthcare Partners I aims to support early-stage companies in the healthcare sector.